JP2017522392A5 - - Google Patents

Download PDF

Info

Publication number
JP2017522392A5
JP2017522392A5 JP2016565146A JP2016565146A JP2017522392A5 JP 2017522392 A5 JP2017522392 A5 JP 2017522392A5 JP 2016565146 A JP2016565146 A JP 2016565146A JP 2016565146 A JP2016565146 A JP 2016565146A JP 2017522392 A5 JP2017522392 A5 JP 2017522392A5
Authority
JP
Japan
Prior art keywords
heparan sulfate
isolated
substantially purified
polypeptide
purified heparan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016565146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017522392A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2015/050092 external-priority patent/WO2015167401A1/en
Publication of JP2017522392A publication Critical patent/JP2017522392A/ja
Publication of JP2017522392A5 publication Critical patent/JP2017522392A5/ja
Pending legal-status Critical Current

Links

JP2016565146A 2014-04-30 2015-04-30 ヘパラン硫酸 Pending JP2017522392A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201401967W 2014-04-30
SG10201401967W 2014-04-30
PCT/SG2015/050092 WO2015167401A1 (en) 2014-04-30 2015-04-30 Heparan sulphates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020082462A Division JP7145909B2 (ja) 2014-04-30 2020-05-08 ヘパラン硫酸

Publications (2)

Publication Number Publication Date
JP2017522392A JP2017522392A (ja) 2017-08-10
JP2017522392A5 true JP2017522392A5 (enExample) 2018-06-14

Family

ID=54358977

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016565146A Pending JP2017522392A (ja) 2014-04-30 2015-04-30 ヘパラン硫酸
JP2020082462A Active JP7145909B2 (ja) 2014-04-30 2020-05-08 ヘパラン硫酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020082462A Active JP7145909B2 (ja) 2014-04-30 2020-05-08 ヘパラン硫酸

Country Status (11)

Country Link
US (1) US10596296B2 (enExample)
EP (1) EP3137509A4 (enExample)
JP (2) JP2017522392A (enExample)
KR (1) KR20170013255A (enExample)
CN (1) CN107001488B (enExample)
AU (1) AU2015253870B2 (enExample)
BR (1) BR112016025443A2 (enExample)
IL (1) IL248608A0 (enExample)
MX (1) MX2016014202A (enExample)
SG (1) SG11201609026UA (enExample)
WO (1) WO2015167401A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3137509A4 (en) * 2014-04-30 2018-03-14 Agency For Science, Technology And Research Heparan sulphates
SG11201705602VA (en) * 2015-01-09 2017-08-30 Agency Science Tech & Res Pdgf-b /pdgf-bb binding variants of heparan sulphates
CN108508129B (zh) * 2018-04-03 2020-11-27 青岛海洋生物医药研究院股份有限公司 一种肝素类药物生物效价的测定方法
CN110646548A (zh) * 2019-10-18 2020-01-03 福州大学 一种提取阿胶中肝素/硫酸类肝素二糖的方法
JPWO2024080183A1 (enExample) * 2022-10-14 2024-04-18

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5843442A (en) * 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
US5807982A (en) 1991-04-29 1998-09-15 Cornell Research Foundation, Inc. Affinity purified heparin
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
KR100688871B1 (ko) * 2002-03-12 2007-03-02 티슈진, 인코포레이티드 연골세포 및 TGF-β를 사용한 연골 재생
ITTO20060282A1 (it) * 2006-04-14 2007-10-15 Univ Degli Studi Torino Mezzo di coltura e composizione farmaceutica per la rigenerazione del tessuto cartilagineo relativo procedimento relativi usi e prodotti
US9498494B2 (en) 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
US9359452B2 (en) * 2009-11-20 2016-06-07 Agency For Science, Technology And Research Isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair
US20130071443A1 (en) 2011-09-16 2013-03-21 Agency For Science, Technology And Research Glycosaminoglycans
SMT201800143T1 (it) * 2011-12-19 2018-05-02 Dilafor Ab Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico
EP3137509A4 (en) * 2014-04-30 2018-03-14 Agency For Science, Technology And Research Heparan sulphates

Similar Documents

Publication Publication Date Title
KR102236805B1 (ko) Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
Einhorn Enhancement of fracture-healing.
US9095569B2 (en) Methods of generating and using procollagen
JP5607176B2 (ja) 新規ペプチドおよびその用途
Pereira et al. Effects of human mesenchymal stem cells isolated from Wharton’s jelly of the umbilical cord and conditioned media on skeletal muscle regeneration using a myectomy model
Lee et al. Human umbilical cord blood–derived mesenchymal stromal cells and small intestinal submucosa hydrogel composite promotes combined radiation-wound healing of mice
CN102886075B (zh) 人体硬组织修复材料及其制备方法
JP2017522392A5 (enExample)
RU2015153735A (ru) Гепарансульфаты
US20210230546A1 (en) Methods for isolation of platelets
Choi et al. Injectable basic fibroblast growth factor-loaded alginate/hyaluronic acid hydrogel for rejuvenation of geriatric larynx
CN111097066A (zh) 一种能够抑制疤痕产生的促伤口愈合医用敷料及其制备方法
Zhang et al. Chemically extracted acellular allogeneic nerve graft combined with ciliary neurotrophic factor promotes sciatic nerve repair
Zhang et al. Preparation and evaluation of tibia-and calvarium-derived decellularized periosteum scaffolds
Wu et al. Rat bone marrow mesenchymal stem cells induced by rrPDGF-BB promotes bone regeneration during distraction osteogenesis
Allen Current approaches to management of vocal fold scar
Galvez et al. In vitro and in vivo assessment of a new acellular human amnion/chorion membrane device for guided bone regeneration
AU2021360235A1 (en) Novel bioactive peptide combinations and uses thereof
US20230010110A1 (en) Histatin-1 formulation for the treatment, repair or regeneration of bone tissue in a subject
Turner et al. Human NELL1 protein augments constructive tissue remodeling with biologic scaffolds
Friedman et al. Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair
US9662417B2 (en) Medical device
Ettey An investigation of collagen, platelet-rich plasma and bone marrow derived mesenchymal stem cells on Achilles tendon repair in a rat model
Lovati et al. Research Article Systemic and Local Administration of Antimicrobial and Cell Therapies to Prevent Methicillin-Resistant Staphylococcus epidermidis-Induced Femoral Nonunions in a Rat Model
Pavlenko et al. THE ROLE OF PLASMA ENRICHED WITH PLATELETS AND GROWTH FACTORS IN MODERN MEDICAL PRACTICE